A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) C07K 14/52 (2006.01) C07K 16/28 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2308126
Methods of modulating LERK-2-mediated cell adhesion, as well as methods of modulating angiogenesis and inflammation are described. Also described are agents such as antibodies which can modulate LERK-2 mediated cell adhesion, as well as methods of treating angiogenic diseases and inflammatory diseases.
L'invention porte sur des procédés de modulation de l'adhésion cellulaire induite par la LERK-2, et des procédés de modulation de l'angiogenèse et de l'inflammation, sur des agents tels que des antibiotiques pouvant moduler l'adhésion cellulaire induite par la LERK-2, et sur des procédés de traitement des maladies angiogènes et inflammatoires.
Briskin Michael J.
Zou Lily
Leukosite Inc.
Millennium Pharmaceuticals Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Modulation of lerk-2-mediated cell adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of lerk-2-mediated cell adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of lerk-2-mediated cell adhesion will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1718049